Showing 751-760 of 8863 results for "".
Breakthroughs in Alopecia Areata Treatment
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/breakthroughs-in-alopecia-areata-treatment/33019/Adelaide A. Hebert, MD, chief of pediatric dermatology at the University of Texas Medical School in Houston, talks about her presentation at Masterclasses in Dermatology 2025 discusses breatkthrough treatments for alopecia areata in patients aged 12 and older.A Key to Successful Teen Acne Treatment
https://practicaldermatology.com/topics/acne-rosacea/Key-Successful-Teen-Acne-Treatment/32981/Acne has a significant psychological aspect that affects the quality of life of adolescents. The appearance of acne often causes feelings of shame, reduced self-esteem, anxiety, and even depression in young people. In some cases, it can lead to difficulties in social adaptation and social isolation,Acne and Rosacea: Dr. Harper
https://practicaldermatology.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.Advantages of More Topical Gel
https://practicaldermatology.com/series/pdt-in-practice/advantages-of-more-topical-gel/29176/Dr. Ashish Bhatia discusses increased dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.The Secret Sauce for Managing AD
https://practicaldermatology.com/conferences/scale-2023/the-secret-sauce-for-managing-ad/20190/James Del Rosso, DO, discusses new and upcoming therapies for atopic dermatitis including monoclonal antibodies and JAK inhibitors.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorSmart Mouth Approaches
https://practicaldermatology.com/conferences/asds-2021/smart-mouth-approaches/20026/When it comes to managing lines around the mouth, the best interventions may include injectables, devices, or both. Joel L. Cohen, MD discusses his favorite approaches to perioral rejuvenation.DermWireTV: COVID Vaccine Approved; Update on Delta and Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-vaccine-approved-update-on-delta-and-dermatology-practice/19998/FDA approval of Pfizer-BioNTech’s Comirnaty COVID-19 Vaccine comes as Coronavirus case rates surge across the US. We take a look at potential implications for dermatology of the Delta variant spread.Hair Care Trends and Treatment Advances
https://practicaldermatology.com/conferences/aad-summer-2021/hair-care-trends-and-treatment-advances/19970/Ronda S. Farah, MD shares highlights from the session she and co-panelists presented on technological advancements in the management of scalp disease. They cover the role of artificial intelligence in monitoring patients, hair cosmetic trends, lasers and platelet rich plasma in 2021, novel technologDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.